Clin Mol Hepatol.
2019 Sep;25(3):331-332. 10.3350/cmh.2019.0034.
Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
- Affiliations
-
- 1Second Propedeutic Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. dipatoulias@gmail.com
- 2Veterans Affairs Medical Center, The George Washington University, Washington, D.C., WA, USA.
- KMID: 2459795
- DOI: http://doi.org/10.3350/cmh.2019.0034
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical impact of nonalcoholic fatty liver disease on other medical diseases
- Relationship between blood leptin and non-alcoholic fatty liver in obese male adolescent
- Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease?
- Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
- Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease
